If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

Related content
Volume 13, Number 9, July 2012

< previous issue | all issues | next issue >

Articles

Favourites:Add to Favourites

In Silico Search for Drug Targets of Natural Compounds
pp. 1632-1639(8)
Author: Yao, Lixia

Favourites:Add to Favourites

Pharmacophore, QSAR, and Binding Mode Studies of Substrates of Human Cytochrome P450 2D6 (CYP2D6) Using Molecular Docking and Virtual Mutations and an Application to Chinese Herbal Medicine Screening
pp. 1640-1704(65)
Authors: Mo, Sui-Lin; Liu, Wei-Feng; Li, Chun-Guang; Zhou, Zhi-Wei; Luo, Hai-Bin; Chew, Helen; Liang, Jun; Zhou, Shu-Feng

Favourites:Add to Favourites
Favourites:Add to Favourites

Attenuated Oncolytic Measles Virus Strains as Cancer Therapeutics
pp. 1732-1741(10)
Authors: Msaouel, P.; D. Iankov, I.; Dispenzieri, A.; Galanis, E.

Favourites:Add to Favourites

Pro-Oncogenic Cell Signaling Machinery as a Target for Oncolytic Viruses
pp. 1742-1749(8)
Authors: Borrego-Diaz, Emma; Mathew, Rajesh; Hawkinson, Dana; Esfandyari, Tuba; Liu, Zhengian; W Lee, Patrick; Farassati, Faris

Favourites:Add to Favourites

Targeted and Armed Oncolytic Poxviruses for Cancer: the Lead Example of JX-594
pp. 1768-1772(5)
Authors: J. Breitbach, Caroline; H. Thorne, Steve; C. Bell, John; H. Kirn, David

Favourites:Add to Favourites

Fusogenic Oncolytic Herpes Simplex Viruses as a Potent and Personalized Cancer Vaccine
pp. 1773-1785(13)
Authors: Li, Qi-Xiang; Liu, Guohong; Zhang, Xiaoliu

Favourites:Add to Favourites

Targeted Oncolytic Herpes Simplex Viruses for Aggressive Cancers
pp. 1786-1794(9)
Authors: Wong, Jennifer; Lee, Cleo; Zhang, Kevin; S. Rennie, Paul; Jia, William

Favourites:Add to Favourites

The Molecular Basis of Herpesviruses as Oncolytic Agents
pp. 1795-1803(9)
Authors: Menotti, Laura; Campadelli-Fiume, Gabriella; Nanni, Patrizia; Luigi Lollini, Pier; De Giovanni, Carla

Favourites:Add to Favourites

Mining the Adenovirus "Virome" for Systemic Oncolytics
pp. 1804-1808(5)
Authors: A. Barry, Michael; A. Weaver, Eric; Y. Chen, Christopher

Favourites:Add to Favourites

Synergistic Interaction of Telomerase-Specific Oncolytic Virotherapy and Chemotherapeutic Agents for Human Cancer
pp. 1809-1816(8)
Authors: Fujiwara, Toshiyoshi; Kagawa, Shunsuke; Tazawa, Hiroshi

Favourites:Add to Favourites

Bugs and Drugs: Oncolytic Virotherapy in Combination with Chemotherapy
pp. 1817-1833(17)
Authors: Tusell Wennier, Sonia; Liu, Jia; McFadden, Grant

Favourites:Add to Favourites

Recent Clinical Experience with Oncolytic Viruses
pp. 1834-1841(8)
Authors: G. Donnelly, O.; Errington-Mais, F.; Prestwich, R.; Harrington, K.; Pandha, H.; Vile, R.; A. Melcher, A.

Favourites:Add to Favourites

Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress
pp. 1842-1851(10)
Authors: Kaur, Balveen; Antonio Chiocca, E.; P. Cripe, Timothy

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more